GALAFOLD 123 mg, hard capsule 14 capsules
Active ingredients: Migalastat hydrochloride, Migalastat
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule14 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- GALAFOLD 123 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC polychlortrifluoroéthylène PVC-Aluminium de 14 gélule(s)
- Marketing authorisation holder
- AMICUS THERAPEUTICS EUROPE (IRLANDE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 2 May 2017
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62876801CIP73006082CIP133400930060827Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MIGALASTATgélule | 123 mg · une gélule | FT |
| CHLORHYDRATE DE MIGALASTATgélule | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.